Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults.

Currier JS, Kendall MA, Henry WK, Alston-Smith B, Torriani FJ, Tebas P, Li Y, Hodis HN.

AIDS. 2007 May 31;21(9):1137-45.

PMID:
17502724
2.

Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure.

Currier JS, Kendall MA, Zackin R, Henry WK, Alston-Smith B, Torriani FJ, Schouten J, Mickelberg K, Li Y, Hodis HN; AACTG 5078 Study Team..

AIDS. 2005 Jun 10;19(9):927-33.

3.

Increased carotid intima media thickness and cardiac biomarkers in HIV infected children.

McComsey GA, O'Riordan M, Hazen SL, El-Bejjani D, Bhatt S, Brennan ML, Storer N, Adell J, Nakamoto DA, Dogra V.

AIDS. 2007 May 11;21(8):921-7.

PMID:
17457085
4.

Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.

Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, Waters DD.

Circulation. 2004 Apr 6;109(13):1603-8. Epub 2004 Mar 15.

5.

Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.

Johnsen S, Dolan SE, Fitch KV, Kanter JR, Hemphill LC, Connelly JM, Lees RS, Lee H, Grinspoon S.

J Clin Endocrinol Metab. 2006 Dec;91(12):4916-24. Epub 2006 Sep 26.

6.

Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults.

Kelesidis T, Yang OO, Kendall MA, Hodis HN, Currier JS.

Lipids Health Dis. 2013 Mar 5;12:23. doi: 10.1186/1476-511X-12-23.

7.

Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors.

Seminari E, Pan A, Voltini G, Carnevale G, Maserati R, Minoli L, Meneghetti G, Tinelli C, Testa S.

Atherosclerosis. 2002 Jun;162(2):433-8.

PMID:
11996964
8.

Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients.

Mercié P, Thiébaut R, Aurillac-Lavignolle V, Pellegrin JL, Yvorra-Vives MC, Cipriano C, Neau D, Morlat P, Ragnaud JM, Dupon M, Bonnet F, Lawson-Ayayi S, Malvy D, Roudaut R, Dabis F; Groupe d'Epidemiologie Clinique du Sida en Aquitaine (GECSA)..

HIV Med. 2005 Nov;6(6):380-7.

9.

Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects.

Papasavvas E, Hsue P, Reynolds G, Pistilli M, Hancock A, Martin JN, Deeks SG, Montaner LJ.

Antivir Ther. 2012;17(3):557-63. doi: 10.3851/IMP2013. Epub 2011 Dec 16.

10.

[Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients].

Ferraro S, Paolillo S, Gargiulo M, Costanzo P, Maggi P, Chirianni A, Chiariello M, Filardi PP.

G Ital Cardiol (Rome). 2009 Sep;10(9):596-601. Italian.

PMID:
19891251
11.

Carotid intima-media thickness in young patients with familial hypercholesterolaemia.

Lavrencic A, Kosmina B, Keber I, Videcnik V, Keber D.

Heart. 1996 Oct;76(4):321-5.

12.

Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study.

Mackinnon AD, Jerrard-Dunne P, Sitzer M, Buehler A, von Kegler S, Markus HS.

Stroke. 2004 Sep;35(9):2150-4. Epub 2004 Jul 8.

13.

Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement.

Soares DV, Spina LD, de Lima Oliveira Brasil RR, da Silva EM, Lobo PM, Salles E, Coeli CM, Conceição FL, Vaisman M.

Metabolism. 2005 Mar;54(3):321-9.

PMID:
15736109
14.
15.

Carotid intima-media thickness in HIV patients treated with antiretroviral therapy.

Lebech AM, Wiinberg N, Kristoffersen US, Hesse B, Petersen CL, Gerstoft J, Kjaer A.

Clin Physiol Funct Imaging. 2007 May;27(3):173-9.

PMID:
17445068
16.

Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors.

Sankatsing RR, Wit FW, Vogel M, de Groot E, Brinkman K, Rockstroh JK, Kastelein JJ, Stroes ES, Reiss P.

Atherosclerosis. 2009 Feb;202(2):589-95. doi: 10.1016/j.atherosclerosis.2008.05.028. Epub 2008 May 28.

PMID:
18599064
17.
18.

Progression of carotid intima-media thickness and coronary artery calcium over 6 years in an HIV-infected cohort.

Volpe GE, Tang AM, Polak JF, Mangili A, Skinner SC, Wanke CA.

J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):51-7. doi: 10.1097/QAI.0b013e31829ed726.

19.

Factors underlying the increase in carotid intima-media thickness in borderline hypertensives.

Pauletto P, Palatini P, Da Ros S, Pagliara V, Santipolo N, Baccillieri S, Casiglia E, Mormino P, Pessina AC.

Arterioscler Thromb Vasc Biol. 1999 May;19(5):1231-7.

20.

Apolipoprotein E gene polymorphisms are associated with carotid plaque formation but not with intima-media wall thickening: results from the Perth Carotid Ultrasound Disease Assessment Study (CUDAS).

Beilby JP, Hunt CC, Palmer LJ, Chapman CM, Burley JP, McQuillan BM, Thompson PL, Hung J; Perth Carotid Ultrasound Disease Assessment Study..

Stroke. 2003 Apr;34(4):869-74. Epub 2003 Mar 13.

Supplemental Content

Support Center